
Iovance Biotherapeutics Inc (IOVA)
NASDAQ
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 238k | 469k | 482k | 715k | 31.11M | 58.56M | 73.69M | 49.32M |
Operating Income | -110.09M | -118.36M | -121.26M | -117.72M | -101.91M | -89.07M | -86.58M | -121.22M |
Pre Tax Income | -107.01M | -115M | -118.14M | -114.38M | -98.56M | -85.06M | -77M | -118M |
Net Income | -106.53M | -113.76M | -116.38M | -112.98M | -97.1M | -83.54M | -78.56M | -116.16M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -110.09M | -118.36M | -121.26M | -117.72M | -101.91M | -89.07M | -86.58M | -121.22M |
EBITDA | -105.26M | -111.43M | -114.4M | -110.11M | -93.44M | -80.5M | -70.7M | -113.03M |
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 1.19M | 164.07M |
Operating Income | -92.88M | -128.26M | -206.87M | -261.94M | -342.7M | -398.88M | -460.56M | -395.28M |
Pre Tax Income | -92.06M | -123.58M | -197.56M | -259.58M | -342.25M | -395.89M | -447.52M | -375.01M |
Net Income | -92.06M | -123.58M | -197.56M | -259.58M | -342.25M | -395.89M | -444.04M | -372.18M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -1.258 | -1.001 | -1.517 | -1.723 | -2.141 | -2.076 | -1.716 | -1.21 |
EBIT | -92.88M | -128.26M | -206.87M | -261.94M | -342.7M | -398.88M | -460.56M | -395.28M |
EBITDA | -91.93M | -127.3M | -205.7M | -260.8M | -339.59M | -389.57M | -439.14M | -354.75M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.